
|Articles|June 19, 2006
ESHRE: Paxil Linked to Abortions, Not Congenital Defects
PRAGUE ? The evidence that led the FDA to warn that Paxil (paroxetine) taken during the first weeks of pregnancy increases the risk of birth defects, including serious heart defects, was disputed by German researchers today.
Advertisement
PRAGUE, June 19 ? The evidence that led the FDA to warn that Paxil (paroxetine) taken during the first weeks of pregnancy increases the risk of birth defects, including serious heart defects, was disputed by German researchers today.
In a German study women who used Paxil were, however, more likely to undergo abortion than women who didn't use an antidepressant during pregnancy (P
Advertisement
Advertisement
Advertisement
Trending on Patient Care Online
1
Early Liver Disease Detection Starts in Primary Care: A Q&A With Stevan Gonzalez, MD
2
Retatrutide Achieved Up to 22.6% Weight Loss in 2 Phase 3 Obesity Trials
3
FDA Clears Roche cobas BV/CV PCR Assay for Simultaneous Vaginitis Detection
4
Newer GLP-1 Therapies Linked to Fewer Alcohol-Related Hospitalizations in Adults With AUD
5



























































































































































